Author： Darvesh Altaf S Carroll Richard T Bishayee Anupam Novotny Nicholas A Geldenhuys Werner J Van der Schyf Cornelis J
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.8, 2012-08, pp. : 1123-1140
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Curcumin: A Boon to Colonic Diseases
Current Drug Targets, Vol. 14, Iss. 10, 2013-09 ,pp. :
Access to resources
Recommend
Cholinergic receptors and neurodegenerative diseases
By Gualtieri F.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :
Chelating Agents for Neurodegenerative Diseases
Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. :
Pharmacogenomics of neurodegenerative diseases
By Maimone D. Dominici R. Grimaldi L.M.E.
European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. :
Receptors in neurodegenerative diseases
By Froestl W.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :